Furthermore, DUSP1 downregulation was associated with activation of MAPK/p38 and MAPK/JNK signaling and accelerated development of hepatosteatosis in NAFLD patients 60. This evidence concerns the gene DUSP1 and metabolic dysfunction-associated steatotic liver disease.